Gino Santini, Director at Collegium Pharmaceutical, holds 112.48K shares in Collegium Pharmaceutical (Ticker: COLL), holds 31.76K shares in Intercept Pharma (Ticker: ICPT), holds ― shares in Allena Pharmaceuticals (Ticker: ALNAQ).
Gino Santini latest transaction was an Uninformative Buy of $143.46K.
What was Gino Santini's most profitable transaction?
Gino Santini’s most profitable transaction was an Informative Sell of COLL stock on August 19, 2025. The return on the trade was 23.60%.
What is Gino Santini's role in Collegium Pharmaceutical?
Gino Santini's role in Collegium Pharmaceutical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.